David Olivier Paul

Title: David Olivier Paul: Innovator in Pharmaceutical Formulations

Introduction

David Olivier Paul is a notable inventor based in Dreux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work focuses on improving the delivery and efficacy of drugs, which is crucial for patient care.

Latest Patents

David Olivier Paul holds a patent for "Formulations containing nalbuphine and uses thereof." This patent describes an immediate release, oral pharmaceutical formulation that comprises nalbuphine or a pharmaceutically acceptable salt thereof. The formulation also includes at least one hydrophilic granulation carrier, one hydrophilic binder, and one lubricant. This innovation aims to enhance the therapeutic effects of nalbuphine, making it more effective for patients.

Career Highlights

David is associated with Debregeas et Associés Pharma, where he applies his expertise in pharmaceutical formulations. His work at the company has allowed him to focus on developing innovative solutions that address the needs of patients and healthcare providers.

Collaborations

Throughout his career, David has collaborated with talented professionals, including Christophe Lebon and Pascal Suplie. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical products.

Conclusion

David Olivier Paul is a dedicated inventor whose work in pharmaceutical formulations has the potential to significantly impact patient care. His innovative approach to drug delivery exemplifies the importance of research and development in the pharmaceutical industry.